EV/EBITDA:
-9.24-0.53(-6.08%)Summary
- As of today (July 11, 2025), ELVN EV/EBITDA is -9.24, with a fall of -0.53 (-6.08%) during the most recent trading session on July 10, 2025.
- Over the past year, ELVN EV/EBITDA has increased by +0.95 (+9.32%).
- ELVN EV/EBITDA is now -110.96% below its all-time high of -4.38.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -6.1% | +6.2% | +5.6% |
| 1 m1 month | -5.5% | +5.5% | +5.0% |
| 3 m3 months | -61.3% | +61.4% | +52.8% |
| 6 m6 months | -2.4% | +8.2% | +4.8% |
| ytdytd | +1.4% | +4.0% | +1.2% |
| 1 y1 year | +9.3% | +2.6% | -1.2% |
| 5 y5 years | - | - | -8.7% |
ELVN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.82 | -18.2% | -9.38 | +1.5% |
| 3 m | 3-month | -5.73 | -61.3% | -9.38 | +1.5% |
| 6 m | 6-month | -5.73 | -61.3% | -9.49 | +2.6% |
| 1 y | 1-year | -5.73 | -61.3% | -13.42 | +31.1% |
| 3 y | 3-year | -4.38 | -111.0% | -23.53 | +60.7% |
| 5 y | 5-year | -4.38 | -111.0% | -23.53 | +60.7% |
| alltime | all time | -4.38 | -111.0% | -23.53 | +60.7% |
ELVN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -9.24(-1.4%) |
| Date | Value |
|---|---|
| 2024 | -9.37(+65.3%) |
| 2023 | -5.67 |
FAQ
- What is Enliven Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Enliven Therapeutics, Inc.?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Enliven Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of ELVN is -9.24
What is the all time high EV/EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high EV/EBITDA is -4.38
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics, Inc. EV/EBITDA has changed by +0.13 (+1.39%) since the beginning of the year
What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by +0.95 (+9.32%)